Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone—impact of luteal estrogen: prospective, randomized study and post hoc analysis
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study investigated luteal phase bleeding patterns in IVF cycles treated with vaginal Crinone gel versus intramuscular progesterone, analyzing the impact of luteal estrogen supplementation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo compare patterns of luteal phase bleeding (LPB) in IVF cycles supplemented with Crinone and with intramuscular progesterone (IMP) and to evaluate the impact of luteal estrogen supplementation on LPB.DesignProspective, randomized trial and post hoc analysis.SettingUniversity-affiliated IVF unit.Patient(s)Women under age 40 with day 3 FSH <15 mIU/mL were randomized to receive either Crinone or IMP for luteal phase support. Luteal estrogen was prescribed according to clinical protocols. Three hundred sixty-five patients were queried about LPB after completion of their IVF cycles.Intervention(s)Luteal phase supplementation with Crinone or IMP and with estrogen.Main outcome measure(s)Incidence of LPB in IVF cycles supplemented with Crinone and IMP and impact of luteal estrogen on the occurrence of LPB.Result(s)There was no difference in the overall incidence of LPB between patients treated with Crinone and those treated with IMP (33.2% vs. 25.7%). LPB occurred with equal frequency among pregnant patients in both arms (Crinone 21.9% vs. IMP 18.6%). Only nonpregnant women had a higher incidence of LPB when treated with Crinone compared with treatment with IMP (56.5% vs.38.1%). Estrogen supplementation decreased the occurrence of LPB among all participants but did not impact pregnancy rates.Conclusion(s)Only nonpregnant women had a higher incidence of bleeding in the luteal phase when supplemented with Crinone compared with treatment with IMP. IMP delays menses in nonpregnant cycles without affecting pregnancy rates. Luteal estrogen decreases LPB without impacting cycle outcomes.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Use of Crinone∗ vaginal progesterone gel for luteal support in in vitro fertilization cycles 1999
- A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 2009
- Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone 2000
Cited by (1)
References (18)
- A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone via openalex
- Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone via openalex
- Use of Crinone∗ vaginal progesterone gel for luteal support in in vitro fertilization cycles via openalex
- doi:10.1016/j.fertnstert.2008.08.064 via openalex
- doi:10.1093/humrep/den115 via openalex
- doi:10.1016/j.fertnstert.2010.02.033 via openalex
- doi:10.1016/j.annemergmed.2005.12.023 via openalex
- W2407929205 via openalex
- W6673771426 via openalex
- W7073722596 via openalex
- doi:10.1097/00006250-200003000-00017 via openalex
- doi:10.1016/s0015-0282(01)02872-2 via openalex
- doi:10.1002/14651858.cd004830 via openalex
- doi:10.1016/j.fertnstert.2007.03.006 via openalex
- doi:10.1016/j.fertnstert.2008.02.095 via openalex
- doi:10.1016/s0015-0282(03)01170-1 via openalex
- doi:10.1016/s0015-0282(16)56935-0 via openalex
- doi:10.1016/s0015-0282(16)49282-4 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:42:58.953575+00:00
License: CC0
· commercial use OK